Matinas Biopharma Holdings Inc. (MTNB)
MTNB trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.50
-8.76% on the day
Market cap
$2.4M
Nano cap
Revenue · 2023
$1.1M
No prior year to compare
Net income · 2023
-$22.9M
-2093.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2023.
Profile
| Field | Value |
|---|---|
| Ticker | MTNB on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2017 |
| SEC CIK | 0001582554 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2023
| Line | Value |
|---|---|
| Revenue | $1.1M |
| Net income | -$22.9M |
| Operating income | -$23.8M |
| Net margin | -2093.2% |
| Operating margin | -2168.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $4.8M |
| Total assets | $25.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2026-06-22 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-28 |
| Latest proxy | DEF 14A | 2025-05-12 |
Source: SEC EDGAR submissions feed, 569 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ELAB | PMGC Holdings Inc. | $2.96 | -2.95% | $2.4M |
| SPRC | SciSparc Ltd. | $3.94 | -3.43% | $2.3M |
| GOVX | GeoVax Labs Inc. | $0.2656 | -5.92% | $2.7M |
| PPBT | Purple Biotech Ltd. | $1.36 | -1.45% | $2.2M |
| SILO | Silo Pharma Inc. | $1.22 | -18.12% | $2.1M |
| KAPA | Kairos Pharma Ltd. | $0.8287 | -0.40% | $2.8M |
| HCWB | HCW Biologics Inc. | $1.26 | -14.87% | $2.8M |
| MBIO | Mustang Bio Inc. | $0.3768 | -8.63% | $2.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier